Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Platelet aggregation and atherosclerosis.

B K Valladares, L Lemberg

    Heart & Lung : the Journal of Critical Care
    |March 1, 1986
    PubMed
    Summary
    This summary is machine-generated.

    Daily aspirin or dipyridamole effectively prevents platelet aggregation, reducing the risk of coronary events and transient ischemic cerebral attacks. These medications are crucial for preventing thrombotic events.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    [Effectiveness and patient tolerance of screening colonoscopy -- first results].

    Zeitschrift fur Gastroenterologie·2004
    Same author

    Herbal or complementary medicine: fact or fiction?

    American journal of critical care : an official publication, American Association of Critical-Care Nurses·2001
    Same author

    Brugada.

    American journal of critical care : an official publication, American Association of Critical-Care Nurses·2001
    Same author

    Heart failure: update on treatment and prognosis.

    American journal of critical care : an official publication, American Association of Critical-Care Nurses·2001
    Same author

    The critical role of the endothelial cell in acute coronary events.

    American journal of critical care : an official publication, American Association of Critical-Care Nurses·2001
    Same author

    The mysteries of the human genome uncovered--medicine is changed forever.

    American journal of critical care : an official publication, American Association of Critical-Care Nurses·2001
    Same journal

    Diagnosing heart failure through imaging.

    Heart & lung : the journal of critical care·2026
    Same journal

    Comparative utility of median household income, social vulnerability index, and social deprivation index in predicting heart failure-related emergency department revisits: A multi-hospital cohort study.

    Heart & lung : the journal of critical care·2026
    Same journal

    Predicting in-hospital mortality in AECOPD: A comparison of the mSOFA score with DECAF, Ottawa, and GOLD classifications.

    Heart & lung : the journal of critical care·2026
    Same journal

    Diagnostic accuracy of serological tests and biomarkers for hypersensitivity pneumonitis: A systematic review.

    Heart & lung : the journal of critical care·2026
    Same journal

    Associations of genetic risk factors and air pollution with incident pulmonary embolism: a prospective cohort study in the UK Biobank.

    Heart & lung : the journal of critical care·2026
    Same journal

    Impaired hemostasis in mechanical circulatory support systems: Monitoring with T-TAS® 01, in vitro correction with VWF concentrates, and impact of membrane oxygenators.

    Heart & lung : the journal of critical care·2026
    See all related articles

    Area of Science:

    • Cardiovascular Medicine
    • Pharmacology
    • Neurology

    Background:

    • Platelet aggregation is a key factor in thrombotic events like heart attacks and strokes.
    • Understanding the mechanisms of platelet activation is crucial for developing preventative therapies.

    Observation:

    • Clinical trials investigated the efficacy of antiplatelet agents in preventing ischemic events.
    • The study focused on the role of aspirin and dipyridamole in managing platelet aggregation.

    Findings:

    • Daily low-dose aspirin (160-325 mg) or dipyridamole (300-400 mg) significantly inhibits platelet aggregation.
    • Combined therapy with aspirin and dipyridamole also demonstrated effectiveness in preventing platelet aggregation.

    Implications:

    Related Experiment Videos

    • These findings support the use of aspirin and dipyridamole for the primary and secondary prevention of coronary and cerebral ischemic attacks.
    • Regular intake of these antiplatelet medications can lead to a statistically significant reduction in the incidence of major cardiovascular and cerebrovascular events.